16066-93-6 Usage
General Description
1-(5-amino-1H-indol-1-yl)ethanone, also known as 5-IAI, is a synthetic chemical compound with the molecular formula C10H11N2O. It belongs to the class of substituted tryptamines, which are known for their hallucinogenic and psychoactive effects. 5-IAI is a potent serotonin reuptake inhibitor and has been found to affect the central nervous system, leading to altered perception, mood, and cognition. It has gained popularity as a recreational drug, often used for its euphoric and empathogenic effects, although it is also associated with various adverse side effects and potential health risks. Due to its psychoactive properties, 5-IAI is classified as a controlled substance in many countries and its use is strictly regulated.
Check Digit Verification of cas no
The CAS Registry Mumber 16066-93-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,6 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16066-93:
(7*1)+(6*6)+(5*0)+(4*6)+(3*6)+(2*9)+(1*3)=106
106 % 10 = 6
So 16066-93-6 is a valid CAS Registry Number.
16066-93-6Relevant articles and documents
Calculated oxidation potentials predict reactivity in Baeyer-Mills reactions
Tombari, Robert J.,Tuck, Jeremy R.,Yardeny, Noah,Gingrich, Phillip W.,Tantillo, Dean J.,Olson, David E.
, p. 7575 - 7580 (2021/09/22)
Azobenzenes are widely used as dyes and photochromic compounds, with the Baeyer-Mills reaction serving as the most common method for their preparation. This transformation is often plagued by low yields due to the formation of undesired azoxybenzene. Here, we explore electronic effects dictating the formation of the azoxybenzene side-product. Using calculated oxidation potentials, we were able to predict reaction outcomes and improve reaction efficiency simply by modulating the oxidation potential of the arylamine component.
HETEROCYCLE-SUBSTITUTED CYCLIC UREA DERIVATIVES, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF AS KINASE INHIBITORS
-
Page/Page column 76, (2010/02/15)
The invention relates to the novel products of formula (I), in which V represents a heterocyclic radical, as protein kinases inhibitors.
